Atlas Trials

Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors

Clinical trial NCT00730223 · COMPLETED

Trial details

NCT number
NCT00730223
Sponsor
Vanderbilt University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
2004-03-01
Primary completion
2006-03-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.